CannapharmaRx, Inc. announced that it has consolidated its Board of Directors to include a team more suitable for the recently announced asset and facility offer acceptance in Saskatchewan and Alberta. Effective March 12, 2021, CannapharmaRX has accepted the resignations from Jim Samuelson and Matt Nicosia, both of whom will focus on other business obligations. The company anticipates announcing replacements for these board members shortly as it continues to transform into a leader in the high-technology cannabis industry.